English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Structural Characterization of Amorfrutins Bound to the Peroxisome Proliferator-Activated Receptor gamma

MPS-Authors
/persons/resource/persons50629

Weidner,  C.
Nutrigenomics and Gene Regulation (Sascha Sauer), Independent Junior Research Groups (OWL), Max Planck Institute for Molecular Genetics, Max Planck Society;

/persons/resource/persons50512

Sauer,  S.
Nutrigenomics and Gene Regulation (Sascha Sauer), Independent Junior Research Groups (OWL), Max Planck Institute for Molecular Genetics, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)

de Groot.pdf
(Publisher version), 5MB

Supplementary Material (public)
There is no public supplementary material available
Citation

de Groot, J. C., Weidner, C., Krausze, J., Kawamoto, K., Schroeder, F. C., Sauer, S., et al. (2013). Structural Characterization of Amorfrutins Bound to the Peroxisome Proliferator-Activated Receptor gamma. Journal of Medicinal Chemistry, 56(4), 1535-1543. doi:10.1021/jm3013272.


Cite as: https://hdl.handle.net/11858/00-001M-0000-0019-1181-C
Abstract
Amorfrutins are a family of natural products with high affinity to the peroxisome proliferator-activated receptor gamma (PPARgamma), a nuclear receptor regulating lipid and glucose metabolism. The PPARgamma agonist rosiglitazone increases insulin sensitivity and is effective against type II diabetes but has severe adverse effects including weight gain. Amorfrutins improve insulin sensitivity and dyslipidemia but do not enhance undesired fat storage. They bear potential as therapeutics or prophylactic dietary supplements. We identified amorfrutin B as a novel partial agonist of PPARgamma with a considerably higher affinity than that of previously reported amorfrutins, similar to that of rosiglitazone. Crystal structures reveal the geranyl side chain of amorfrutin B as the cause of its particularly high affinity. Typical for partial agonists, amorfrutins 1, 2, and B bind helix H3 and the beta-sheet of PPARgamma but not helix H12.